Detalles de la búsqueda
1.
Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic.
Am J Infect Control;
2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537678
2.
Co-production of the quality of patient-centered outcomes research partnerships instrument for people with mental health conditions.
Patient Exp J;
8(1): 148-156, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35330862
3.
Strategies for the successful implementation of disinfecting port protectors to reduce CLABSI in a large tertiary care teaching hospital.
Am J Infect Control;
47(12): 1505-1507, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324493
4.
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors.
J Med Chem;
58(7): 2967-87, 2015 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25760409
5.
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.
J Med Chem;
58(3): 1159-83, 2015 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25590515
6.
Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice.
J Huntingtons Dis;
3(2): 159-74, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25062859
7.
Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
J Med Chem;
57(8): 3205-12, 2014 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24660890
8.
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.
J Med Chem;
56(24): 9934-54, 2013 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24261862
9.
Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2- (2,5-difluorophenyl)-5-(4,6-dihydropyrrolo [3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23) [corrected].
Bioorg Med Chem Lett;
23(19): 5361-6, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23972441
10.
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.
Bioorg Med Chem;
20(9): 2845-9, 2012 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22494842
11.
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
ACS Med Chem Lett;
3(3): 252-6, 2012 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24900461
12.
Bicyclo[2.2.2]octyltriazole inhibitors of 11ß-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome.
Bioorg Med Chem Lett;
21(8): 2568-72, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21421311
13.
Substituted phenyl triazoles as selective inhibitors of 11ß-Hydroxysteroid Dehydrogenase Type 1.
Bioorg Med Chem Lett;
21(7): 2141-5, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21334894
14.
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
J Pharmacol Exp Ther;
336(2): 356-64, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21036912
15.
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality.
ACS Med Chem Lett;
2(12): 933-7, 2011 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24900283
16.
Substituted biaryl pyrazoles as sodium channel blockers.
Bioorg Med Chem Lett;
20(18): 5480-3, 2010 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20709545
17.
Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.
Bioorg Med Chem Lett;
20(18): 5536-40, 2010 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20709552
18.
CCR5 blockade modulates inflammation and alloimmunity in primates.
J Immunol;
179(4): 2289-99, 2007 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17675490
19.
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin.
Bioorg Med Chem Lett;
17(12): 3384-7, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17433672
20.
Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
Bioorg Med Chem Lett;
17(7): 1903-7, 2007 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17291750